Share on:
Arcam acquired its strategic contract manufacturing partner, DiSanto Technology, for US $15.8MM in cash and stock. For the last 12 months, DiSanto generated revenue of ~$12MM. DiSanto will become a subsidiary of Arcam and will continue operations under its existing management. (Source: Arcam)
RELATED ARTICLES
Norwood Medical Appoints Gregg Olson as VP Sales & Marketing
Mar 27 2024 , Julie A. Vetalice
Tapping into the Promising Potential of AI in Orthopedics
Mar 26 2024 , BONEZONE Editors
4 Benefits of Additive Manufacturing Design in the Orthopedic Market
Mar 25 2024 , Paragon Medical
Materials Solutions for Medical Device Instrumentation
Mar 22 2024 , Carpenter Technology